IQVIA introduced IQVIA Life Science Models, a suite of purpose-built models for life sciences, at TechIQ 2026. The models combine IQVIA's proprietary expert content, deep domain knowledge and established regulatory, compliance and privacy frameworks, and are built using technologies including NVIDIA Nemotron and supported by Amazon Web Services infrastructure. In initial evaluation across 50 trials and 270 endpoints, 85% of predictions were on target or clinically close. The models enable clinical study simulation and protocol optimization, including endpoint selection, patient eligibility criteria, dose selection and sample size planning, as well as digital twins and synthetic controls that support more efficient study designs. In clinical development, Life Science Models extend IQVIA's Predictive Clinical Development approach, enabling sponsors to simulate studies and test key assumptions before execution.
Amazon.com Inc
NVIDIA CorporationIQVIA Holdings IncIQVIA launched its Life Science Models suite for clinical trial simulation and protocol optimization, a new product development.
